Replies to post #246125 on Biotech Values

[DewDiligence]

Re: iHub erosion due to Twitter—(and_other_social_media)

I wish this board was as active as it was in the 2000s though. …with the proliferation of social media it's to be expected, though.

True; by far the main competitor for biotech investing discussion is Twitter. Several regular contributors on iHub left for Twitter and have not returned, although a few have seen what Twitter has to offer and have come back to iHub.

Each platform has its strengths and weaknesses. Twitter gives you exposure to many more biotech investors and biotech gurus than you can get on this board, but Twitter is also rather awkward when it comes to having an in-depth discussion.